New research presented at the European Congress on Obesity (ECO 2026) suggests that greater weight loss while taking popular GLP-1 medications such as Ozempic, Wegovy, Saxenda, and Mounjaro may significantly reduce the risk of several…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply